Core Insights - The company held an online performance briefing on November 21, 2025, discussing its Q3 2025 operational and financial status, as well as product developments [1] Group 1: Business Performance - As of the end of Q3 2025, the company's products have entered 67 countries and regions, with nearly 3,300 product import licenses obtained, laying a solid foundation for overseas market expansion [1] - In Q3 2025, the company achieved overseas regular product revenue of 51 million yuan, a year-on-year increase of 47.34% and a quarter-on-quarter increase of 23.78% [1] - For the first three quarters of 2025, the company reported overseas self-produced regular product revenue of 124 million yuan, a year-on-year increase of 46.21%, with the POCT product line contributing 99 million yuan, up 41.61% year-on-year [1][2] Group 2: Growth Drivers - The growth in overseas business, particularly in the POCT product line, is attributed to the company's focus on international markets, optimizing the management structure of the international trade department, and enhancing product recognition [2] - The company has obtained 109 registration projects for chemiluminescence, covering key disease areas such as cardiovascular, inflammation, infectious diseases, tumor markers, thyroid function, glucose metabolism, and sex hormones [2] - The detection volume of chemiluminescence reagents increased by over 30% year-on-year, indicating a sustained improvement in market recognition and the effectiveness of the strategy to drive reagent consumption through instrument installations [2] Group 3: Future Outlook - The company plans to continue investing in R&D, focusing on instrument iteration, expanding the testing menu, and upgrading core raw material development to enhance product competitiveness and accelerate the import substitution process [3] - For the first three quarters of 2025, the company's combined sales, management, and R&D expenses totaled 36.8 million yuan, a decrease of 11.47% year-on-year, reflecting effective cost control [3] - The company aims to deepen refined management, improve resource allocation efficiency, and implement precise resource deployment in marketing while achieving digital control of expenses through an intelligent expense management system [3]